Islam, S.; Espitia, C.M.; Persky, D.O.; Carew, J.S.; Nawrocki, S.T.
Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma. Viruses 2021, 13, 1406.
https://doi.org/10.3390/v13071406
AMA Style
Islam S, Espitia CM, Persky DO, Carew JS, Nawrocki ST.
Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma. Viruses. 2021; 13(7):1406.
https://doi.org/10.3390/v13071406
Chicago/Turabian Style
Islam, Shariful, Claudia M. Espitia, Daniel O. Persky, Jennifer S. Carew, and Steffan T. Nawrocki.
2021. "Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma" Viruses 13, no. 7: 1406.
https://doi.org/10.3390/v13071406
APA Style
Islam, S., Espitia, C. M., Persky, D. O., Carew, J. S., & Nawrocki, S. T.
(2021). Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma. Viruses, 13(7), 1406.
https://doi.org/10.3390/v13071406